52W Range | $2.15-$6.98 |
Market Cap | $2.1B |
Shares Short | 2M |
Revenue (12 Mos) | $2.4B |
Revenue Growth (YoY) | 18.2% |
Gross Profit (12 Mos) | $791.4M |
Diluted EPS | -$0.73 |
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 7,850 |